Tumor Lysis Syndrome Due to Pembrolizumab Use in Metastatic Nasopharyngeal Carcinoma

TURHAN, Aykut; HANNARİCİ, ZEKERİYA; BÜYÜKBAYRAM, MEHMET EMİN; ÇAĞLAR, ALPEREN AKANSEL; ÇOBAN EŞDUR, PINAR; Bilici, Mehmet; TEKİN, SALİM BAŞOL

doi:10.5152/abcr.2024.23149

Makale Tam Makale Ulusal 2024

Tumor Lysis Syndrome Due to Pembrolizumab Use in Metastatic Nasopharyngeal Carcinoma

Aykut TURHAN, ZEKERİYA HANNARİCİ, MEHMET EMİN BÜYÜKBAYRAM, ALPEREN AKANSEL ÇAĞLAR, PINAR ÇOBAN EŞDUR, Mehmet Bilici, SALİM BAŞOL TEKİN

Archives of basic and clinical research Cilt 6 · Sayı 1 · ss. 73–76 · 01.02.2024

DOI ile aç

Atıf için künye

TURHAN, A., HANNARİCİ, Z., BÜYÜKBAYRAM, M. E., ÇAĞLAR, A. A., ÇOBAN EŞDUR, P., Bilici, M., & TEKİN, S. B. (2024). Tumor Lysis Syndrome Due to Pembrolizumab Use in Metastatic Nasopharyngeal Carcinoma. Archives of basic and clinical research, 6(1), 73–76. https://doi.org/10.5152/abcr.2024.23149

BibTeX

@article{turhan2024-228425,
  author = {TURHAN, Aykut and HANNARİCİ, ZEKERİYA and BÜYÜKBAYRAM, MEHMET EMİN and ÇAĞLAR, ALPEREN AKANSEL and ÇOBAN EŞDUR, PINAR and Bilici, Mehmet and TEKİN, SALİM BAŞOL},
  title = {Tumor Lysis Syndrome Due to Pembrolizumab Use in Metastatic Nasopharyngeal Carcinoma},
  journal = {Archives of basic and clinical research},
  year = {2024},
  volume = {6},
  number = {1},
  pages = {73--76},
  issn = {2687-4520},
  doi = {10.5152/abcr.2024.23149},
  url = {https://akademik.atauni.edu.tr/yayinlar/228425-tumor-lysis-syndrome-due-to-pembrolizumab-use-in-metastatic-nasopharyngeal}
}